Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
RalphW. deVere White, Alexander Tsodikov, EschelleC. Stapp, StephanieE. Soares, Hajime Fujii & RobertM. Hackman. (2010) Effects of a High Dose, Aglycone-Rich Soy Extract on Prostate-Specific Antigen and Serum Isoflavone Concentrations in Men With Localized Prostate Cancer. Nutrition and Cancer 62:8, pages 1036-1043.
Read now
Read now
Nurdan Tacyildiz, Derya Ozyoruk, Gulsan Yavuz, Emel Unal, Handan Dincaslan, Figen Dogu, Kazim Sahin & Omer Kucuk. (2010) Soy Isoflavones Ameliorate the Adverse Effects of Chemotherapy in Children. Nutrition and Cancer 62:7, pages 1001-1005.
Read now
Read now
Huanjie Yang, Jeffrey A Zonder & Q Ping Dou. (2009) Clinical development of novel proteasome inhibitors for cancer treatment. Expert Opinion on Investigational Drugs 18:7, pages 957-971.
Read now
Read now
Articles from other publishers (36)
Raffaella Di Napoli, Nunzia Balzano, Annamaria Mascolo, Carla Cimmino, Antonio Vitiello, Andrea Zovi, Annalisa Capuano & Mariarosaria Boccellino. (2023) What Is the Role of Nutraceutical Products in Cancer Patients? A Systematic Review of Randomized Clinical Trials. Nutrients 15:14, pages 3249.
Crossref
Crossref
Rebecca Ahlin, Natalja P. Nørskov, Sanna Nybacka, Rikard Landberg, Viktor Skokic, Johan Stranne, Andreas Josefsson, Gunnar Steineck & Maria Hedelin. (2023) Effects on Serum Hormone Concentrations after a Dietary Phytoestrogen Intervention in Patients with Prostate Cancer: A Randomized Controlled Trial. Nutrients 15:7, pages 1792.
Crossref
Crossref
Rebecca Ahlin, Sanna Nybacka, Andreas Josefsson, Johan Stranne, Gunnar Steineck & Maria Hedelin. (2022) The effect of a phytoestrogen intervention and impact of genetic factors on tumor proliferation markers among Swedish patients with prostate cancer: study protocol for the randomized controlled PRODICA trial. Trials 23:1.
Crossref
Crossref
Katharine E. Reed, Juliana Camargo, Jill Hamilton-Reeves, Mindy Kurzer & Mark Messina. (2021) Neither soy nor isoflavone intake affects male reproductive hormones: An expanded and updated meta-analysis of clinical studies. Reproductive Toxicology 100, pages 60-67.
Crossref
Crossref
Ana Marta de Matos, Maria Teresa Blázquez-Sánchez, Carla Sousa, Maria Conceição Oliveira, Rodrigo F. M. de Almeida & Amélia P. Rauter. (2021) C-Glucosylation as a tool for the prevention of PAINS-induced membrane dipole potential alterations. Scientific Reports 11:1.
Crossref
Crossref
Nagi B. Kumar, Julio Pow-Sang, Philippe Spiess, Shohreh Dickinson & Michael J. Schell. (2020) A phase II randomized clinical trial using aglycone isoflavones to treat patients with localized prostate cancer in the pre-surgical period prior to radical prostatectomy. Oncotarget 11:14, pages 1218-1234.
Crossref
Crossref
Priya Sharma, Praveen Guleria & Vineet Kumar. 2020. Biotechnological Production of Bioactive Compounds. Biotechnological Production of Bioactive Compounds
391
407
.
Monika Sivoňov�, Peter Kapl�n, Zuzana Tatarkov�, Lucia Lichardusov�, R�bert Dušenka & Jana Jurečekov�. (2018) Androgen receptor and soy isoflavones in prostate cancer (Review). Molecular and Clinical Oncology.
Crossref
Crossref
Evan Kovac, Andrew J. Stephenson, Margaret G. House, Eric A. Klein & Howard L. Parnes. 2018. Cancer Prevention and Screening. Cancer Prevention and Screening
145
170
.
Suleman S. Hussain, Addanki P. Kumar & Rita Ghosh. (2016) Food-based natural products for cancer management: Is the whole greater than the sum of the parts?. Seminars in Cancer Biology 40-41, pages 233-246.
Crossref
Crossref
Suman Suman, Trinath P. Das, Jim Moselhy, Deeksha Pal, Venkatesh Kolluru, Houda Alatassi, Murali K. Ankem & Chendil Damodaran. (2016) Oral administration of withaferin A inhibits carcinogenesis of prostate in TRAMP model. Oncotarget 7:33, pages 53751-53761.
Crossref
Crossref
Momoe Itsumi, Masaki Shiota, Ario Takeuchi, Eiji Kashiwagi, Junichi Inokuchi, Katsunori Tatsugami, Shunichi Kajioka, Takeshi Uchiumi, Seiji Naito, Masatoshi Eto & Akira Yokomizo. (2016) Equol inhibits prostate cancer growth through degradation of androgen receptor by S‐phase kinase‐associated protein 2. Cancer Science 107:7, pages 1022-1028.
Crossref
Crossref
Jinjing He, Shuai Wang, Mi Zhou, Weiwen Yu, Yuelong Zhang & Xiang He. (2015) Phytoestrogens and risk of prostate cancer: a meta-analysis of observational studies. World Journal of Surgical Oncology 13:1.
Crossref
Crossref
Gregory B. Lesinski, Patrick K. Reville, Thomas A. Mace, Gregory S. Young, Jennifer Ahn-Jarvis, Jennifer Thomas-Ahner, Yael Vodovotz, Zeenath Ameen, Elizabeth Grainger, Kenneth Riedl, Steven Schwartz & Steven K. Clinton. (2015) Consumption of Soy Isoflavone Enriched Bread in Men with Prostate Cancer Is Associated with Reduced Proinflammatory Cytokines and Immunosuppressive Cells. Cancer Prevention Research 8:11, pages 1036-1044.
Crossref
Crossref
Seher Karsli-Ceppioglu, Marjolaine Ngollo, Gaëlle Judes, Frédérique Penault-LLorca, Yves-Jean Bignon, Laurent Guy & Dominique Bernard-Gallon. 2015. Mechanism of the Anticancer Effect of Phytochemicals. Mechanism of the Anticancer Effect of Phytochemicals
193
221
.
Ana Rodriguez-Mateos, David Vauzour, Christian G. Krueger, Dhanansayan Shanmuganayagam, Jess Reed, Luca Calani, Pedro Mena, Daniele Del Rio & Alan Crozier. (2014) Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update. Archives of Toxicology 88:10, pages 1803-1853.
Crossref
Crossref
Yiwei Li, Aamir Ahmad, Dejuan Kong, Bin Bao & Fazlul H. Sarkar. (2013) Recent progress on nutraceutical research in prostate cancer. Cancer and Metastasis Reviews 33:2-3, pages 629-640.
Crossref
Crossref
M. Diana van Die, Kerry M. Bone, Scott G. Williams & Marie V. Pirotta. (2014) Soy and soy isoflavones in prostate cancer: a systematic review and meta‐analysis of randomized controlled trials. BJU International 113:5b.
Crossref
Crossref
Renata Nowak, Marta Olech & Natalia Nowacka. 2014. Polyphenols in Human Health and Disease. Polyphenols in Human Health and Disease
1289
1307
.
Howard L. Parnes, Margaret G. House & Joseph A. Tangrea. 2014. Prostate Cancer Prevention. Prostate Cancer Prevention
121
131
.
G. Sütfels, F. Saha, N. Altner & G. Dobos. 2014. Uroonkologie. Uroonkologie
261
316
.
Ganna Chornokur & Nagi B. Kumar. (2013) Prostate cancer chemoprevention in men of African descent: current state of the art and opportunities for future research. Cancer Causes & Control 24:8, pages 1465-1480.
Crossref
Crossref
Jill M. Hamilton-Reeves, Snigdha Banerjee, Sushanta K. Banerjee, Jeffrey M. Holzbeierlein, J. Brantley Thrasher, Suman Kambhampati, John Keighley & Peter Van Veldhuizen. (2013) Short-Term Soy Isoflavone Intervention in Patients with Localized Prostate Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial. PLoS ONE 8:7, pages e68331.
Crossref
Crossref
Howard L. Parnes, Margaret G. House & Joseph A. Tangrea. (2013) Prostate cancer prevention. Current Opinion in Oncology 25:3, pages 242-251.
Crossref
Crossref
Nagi B. Kumar, Medha Dhurandhar, Bharat Aggarwal, Shrikant Anant, Kenyon Daniel, Gary Deng, Julie Djeu, Jinhui Dou, Ernest Hawk, B. Jayaram, Libin Jia, Rajendra Joshi, Madhuri Kararala, Devarajan Karunagaran, Omer Kucuk, Lalit Kumar, Mokenge Malafa, G. J. Samathanam, Fazlul Sarkar, Maqsood Siddiqi, Rana P. Singh, Anil Srivastava & Jeffrey D. White. (2012)
Proceedings of the
I
ndo‐
U.S.
bilateral workshop on accelerating botanicals/biologics agent development research for cancer chemoprevention, treatment, and survival
. Cancer Medicine 2:1, pages 108-115.
Crossref
Crossref
Dana Shor, Thozhukat Sathyapalan, Stephen L. Atkin & Natalie J. Thatcher. (2012) Does equol production determine soy endocrine effects?. European Journal of Nutrition 51:4, pages 389-398.
Crossref
Crossref
Nagi Kumar, Theresa Crocker, Tiffany Smith, Julio Pow-Sang, Philippe E. Spiess, Kathleen Egan, Gwen Quinn, Michael Schell, Said Sebti, Aslam Kazi, Tian Chuang, Raoul Salup, Mohamed Helal, Gregory Zagaja, Edouard Trabulsi, Jerry McLarty, Tajammul Fazili, Christopher R. Williams, Fred Schreiber, Joel Slaton & J. Kyle Anderson. (2012) Challenges and potential solutions to meeting accrual goals in a Phase II chemoprevention trial for prostate cancer. Contemporary Clinical Trials 33:2, pages 279-285.
Crossref
Crossref
Yiwei Li, Dejuan Kong, Aamir Ahmad, Bin Bao & Fazlul H. Sarkar. 2012. Nutraceuticals and Cancer. Nutraceuticals and Cancer
355
376
.
Nagi B. KumarNagi B. Kumar. 2012. Nutritional Management of Cancer Treatment Effects. Nutritional Management of Cancer Treatment Effects
193
219
.
Gilda G. Hillman & Vinita Singh-Gupta. (2011) Soy isoflavones sensitize cancer cells to radiotherapy. Free Radical Biology and Medicine 51:2, pages 289-298.
Crossref
Crossref
Paul L De Souza, Pamela J Russell, John H Kearsley & Laurence G Howes. (2010) Clinical pharmacology of isoflavones and its relevance for potential prevention of prostate cancer. Nutrition Reviews 68:9, pages 542-555.
Crossref
Crossref
Jill M. Hamilton-Reeves, Gabriela Vazquez, Sue J. Duval, William R. Phipps, Mindy S. Kurzer & Mark J. Messina. (2010) Clinical studies show no effects of soy protein or isoflavones on reproductive hormones in men: results of a meta-analysis. Fertility and Sterility 94:3, pages 997-1007.
Crossref
Crossref
Tatyana Isayeva, Lakisha D. Moore, Diptiman Chanda, Dongquan Chen & Selvarangan Ponnazhagan. (2009) Tumoristatic effects of endostatin in prostate cancer is dependent on androgen receptor status. The Prostate 69:10, pages 1055-1066.
Crossref
Crossref
Felix Joyonto Saha, Gerrit Sütfels, Nils Altner & Gustav Dobos. 2009. Uroonkologie. Uroonkologie
215
268
.
Sanjeev Banerjee, Yiwei Li, Zhiwei Wang & Fazlul H. Sarkar. (2008) Multi-targeted therapy of cancer by genistein. Cancer Letters 269:2, pages 226-242.
Crossref
Crossref
Ioannis Sainis, Katerina Vareli, Vasilios Karavasilis & Evangelos Briasoulis. (2008) PPAR: The Portrait of a Target Ally to Cancer Chemopreventive Agents. PPAR Research 2008, pages 1-10.
Crossref
Crossref